EUCTR2011-005114-11-IT进行中（未招募）不适用
Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes - SWITCH OVER trial
AZIENDA USL DI FORLI'0 个研究点开始时间: 2011年12月22日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age > 18 year old with typical chest pain lasting >30 min and at least one of the following features: ST-segment shift >1 mV in 2 adjacent ECG leads and/or the presence of negative T-waves (?3 mm depth) or the isolated elevation of cardiac troponin T.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Any prior thienopyridine treatment, planned upstream treatment” with IIB/IIIA intravenous receptor blockers (GPI), need for chronic oral anticoagulation, recent fibrinolytic administration, increased bleeding risk or anaemia. We will also exclude patients with body weight 60 kg and/or ?75 yrs old patients ( to exclude patients indicated for 5 mg MD which would introduce further noise into pharmacodynamic comparison due to the small numbers of observations) and patients with a previous history of TIA/stroke (contraindicated).
研究者
相似试验
尚未招募
不适用
Impact of switching therapy of prasugrel to clopidogrelon platlet reaction in patients with acute coronary syndrome .acute coronary syndromeJPRN-UMIN000014283Department of Cardiovascular Medicine Shinshu University Hospital20
进行中（未招募）
不适用
Doubler la dose du clopidogrel ou passer au Prasugrel pour contrer l’interaction liée aux inhibiteurs de pompe à protons - DOSAPIMaladie des artères coronairesMedDRA version: 12.1Level: LLTClassification code 10011099Term: Coronary diseaseEUCTR2010-019154-40-FRMedco Health Solutions, Inc.
进行中（未招募）
1 期
Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44 - Principle -TIMI 44EUCTR2006-000813-39-FREli Lilly and Company180
进行中（未招募）
不适用
Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44 - Principle -TIMI 44subjects undergoing elective cardiac catheterization with planned percutaneous coronary intervention (PCI) with coronary stenting.EUCTR2006-000813-39-DEEli Lilly and Company180
进行中（未招募）
不适用
The effect of clopidogrel and prasugrel with and without acetylsalicylic acid (ASA) on hemostatic system activation at the site of plug formation in vivo in macoronary artery disease and acute coronary syndromeEUCTR2010-019643-19-ATMedizinische Universität Wien, Univ.Klinik f.Innere Medizin I, Abt.f.Hämatologie u.Hämostaseologie